BioTelemetry, Inc (BEAT)

Etorro trading 970x250
BioTelemetry, Inc (BEAT) Logo

About BioTelemetry, Inc

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania. As of February 9, 2021, BioTelemetry, Inc. operates as a subsidiary of Philips Holding USA Inc. Address: 1000 Cedar Hollow Road, Malvern, PA, United States, 19355

BioTelemetry, Inc News and around…

Latest news about BioTelemetry, Inc (BEAT) common stock and company :

Philips Divests Appliances Business To Hillhouse For $4.4B: Bloomberg
25 Mar, 2021 FinancialContent

Royal Philips NV(NYSE:PHG) is divesting its domestic-appliances unit to private equity firm Hillhouse Capital in a deal ...

CB Scientific (Stock Symbol: CBSC) today announced 3 Major Hospital chains will use Remote Cardiac Monitoring Services in Thailand with CBSC’s my-Cam device.
16 Mar, 2021 FinancialContent
CB Scientific, Inc. (OTC:CBSC) Is a Rising Entry Into the Multi-Billion Dollar Cardiac Monitoring Medical Device and Technology Software Field
01 Mar, 2021 FinancialContent
CB Scientific, Inc. (Stock Symbol: CBSC) is a Rising Entry into the Multi-Billion Dollar Cardiac Monitoring Medical Device and Technology Software Field with FDA and CE Cleared Products and Technology
23 Feb, 2021 FinancialContent
CB Scientific, Inc. (Stock Symbol: CBSC) is a Rising Entry into the Multi-Billion Dollar Cardiac Monitoring Medical Device and Technology Software Field with FDA and CE Cleared Products & Technology
22 Feb, 2021 FinancialContent
CB Scientific Stock Symbol: CBSC is FDA/CE Cleared Cardiac Medical & Technology products for a Multi-Billion Dollar Ind.
22 Feb, 2021 FinancialContent
Philips completes the acquisition of BioTelemetry, Inc.
09 Feb, 2021 FinancialContent
Philips successfully completes tender offer for BioTelemetry, Inc.
09 Feb, 2021 FinancialContent
Why Shares of Investors Bancorp Are Rising Today
03 Feb, 2021 FinancialContent

The bank recently got added to the S&P SmallCap 600 Index.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ALXN, MGLN, FLIR, BEAT; Shareholders Are Encouraged to Contact the Firm
07 Jan, 2021 FinancialContent
Moore Kuehn Encourages TNAV, ATAC, BEAT, and FTIV Investors to Contact Law Firm
07 Jan, 2021 FinancialContent
Lifshitz Law Firm, P.C. Announces Investigation of BEAT, HBAN, and CKH
03 Jan, 2021 FinancialContent
P/E Ratio Insights for BioTelemetry
30 Dec, 2020 FinancialContent

In the current market session,BioTelemetry Inc. (NASDAQ: BEAT)is trading at $72.11, after ...

Benzinga's Top Upgrades, Downgrades For December 30, 2020
30 Dec, 2020 FinancialContent

Downgrades Truist Securities downgraded the previous rating for BioTelemetry Inc (NASDAQ:BEAT) from Buy to Hold. ...

Biotech Hot Stock CBSC, CB Scientific, Inc. is a Rising Entry into the Multi-Billion Dollar Non-Invasive Cardiac Monitoring Medical Device and Software Field; New Acquisition in Play for Established E
29 Dec, 2020 FinancialContent
CB Scientific, Inc. (OTC: CBSC) is a Rising Entry into the Multi-Billion Dollar Non-Invasive Cardiac Monitoring Medical Device and Software Field
28 Dec, 2020 FinancialContent
CORRECTING and REPLACING BIOTELEMETRY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioTelemetry, In
28 Dec, 2020 FinancialContent

Please replace the release dated December 23, 2020 with the following corrected version due to multiple revisions.

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies – BEAT, HBAN, PS, CKH
22 Dec, 2020 FinancialContent
Moore Kuehn Encourages BEAT, AJRD, ANCN, and RNET Investors to Contact Law Firm
21 Dec, 2020 FinancialContent
78 Biggest Movers From Friday
21 Dec, 2020 FinancialContent

Gainers 908 Devices Inc. (NASDAQ: MASS) shares surged 145% to close at $49.00 on Friday after the company priced its IPO at $20 ...

(BEAT) Alert: Johnson Fistel Investigates Proposed Sale of BioTelemetry; Is $72 a Fair Price?
19 Dec, 2020 FinancialContent
BIOTELEMETRY ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of BEAT and Encourages Investors to Contact the Firm
18 Dec, 2020 FinancialContent
Notable Friday Option Activity: CURO, BEAT, USCR
18 Dec, 2020 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Curo Group Holdings Corp (CURO), where a total volume of 10,495 contracts has been traded thus far today, a contract volume which is representative of approximately 1.0 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 726.1% of CURO's average daily trading volume over the past month, of 144,530 shares..

Stocks That Hit 52-Week Highs On Friday
18 Dec, 2020 FinancialContent

Friday's session saw 466 companies set new 52-week highs. Key Facts: Tesla (NASDAQ: TSLA) was the company with ...

12 Health Care Stocks Moving In Friday's Intraday Session
18 Dec, 2020 FinancialContent

Gainers Mereo BioPharma Group (NASDAQ:MREO) shares moved upwards by 53.39% to $3.39 during Friday's regular session. ...

54 Stocks Moving In Friday's Mid-Day Session
18 Dec, 2020 FinancialContent

Gainers Presidio Property Trust, Inc. (NASDAQ: SQFT) shares climbed 157% to $9.51 after jumping over 26% on Thursday. CURO ...

ROCE Insights For BioTelemetry
18 Dec, 2020 FinancialContent

Looking at Q3, BioTelemetry (NASDAQ: BEAT) earned $11.89 million, a 96.85% increase from the preceding quarter. BioTelemetry also posted ...

Benzinga's Top Upgrades, Downgrades For December 18, 2020
18 Dec, 2020 FinancialContent

Upgrades According to Citigroup, the prior rating for H.B. Fuller Co (NYSE:FUL) was changed from Neutral to Buy. In the ...

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of BioTelemetry, Inc. Buyout
18 Dec, 2020 FinancialContent
BioTelemetry Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of BioTelemetry, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – BEAT
18 Dec, 2020 FinancialContent

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of BioTelemetry, Inc. (NASDAQ: BEAT) to Royal Philips for $72.00 per share in cash is fair to BioTelemetry shareholders.

BioTelemetry, Inc (BEAT) is a NASDAQ Common Stock listed in , ,

970x250